Status:

ACTIVE_NOT_RECRUITING

Study of Selected X-linked Disorders: Goltz Syndrome

Lead Sponsor:

Baylor College of Medicine

Conditions:

Focal Dermal Hypoplasia (FDH)

Goltz Syndrome

Eligibility:

All Genders

Brief Summary

Focal dermal hypoplasia, or Goltz syndrome, results from genetic changes, or mutations in the PORCN gene located on the X chromosome. This neurodevelopmental disorder is characterized by birth defects...

Detailed Description

Goltz syndrome or Focal Dermal Hypoplasia (FDH) is an X-linked dominant neurodevelopmental disorder. The primary features of FDH include areas of hypoplastic skin (atrophy, linear pigmentation and her...

Eligibility Criteria

Inclusion

  • Features suggestive of Goltz syndrome (not all features must be present)
  • Areas of hypoplastic skin
  • Digital patterning defects
  • Ocular and dental malformations
  • Presence of a mutation in PORCN

Exclusion

  • None

Key Trial Info

Start Date :

June 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2030

Estimated Enrollment :

84 Patients enrolled

Trial Details

Trial ID

NCT00691223

Start Date

June 1 2007

End Date

January 1 2030

Last Update

August 16 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Baylor College of Medicine

Houston, Texas, United States, 77030

Study of Selected X-linked Disorders: Goltz Syndrome | DecenTrialz